Literature DB >> 2863150

Inhibition of diazepam metabolism in microsomal- and perfused liver preparations of the rat by desmethyldiazepam, N-methyloxazepam and oxazepam.

E M Savenije-Chapel, A Bast, J Noordhoek.   

Abstract

Hydroxylated metabolites of diazepam can be conjugated and are therefore generally thought not to affect the metabolism of diazepam. Liver microsomes, obtained from phenobarbital-pretreated rats, showed an inhibition of diazepam (10(-5) M) metabolism by desmethyldiazepam as well as by N-methyloxazepam or oxazepam (5 X 10(-5) M). In a single-pass perfusion of the rat liver an inhibition of diazepam disposition by exogenously administered desmethyldiazepam and by hydroxylated diazepam metabolites was also demonstrated. No oxazepam glucuronides were found after oxazepam infusion. However, infusion with N-methyloxazepam resulted in large amounts of oxazepam-glucuronides. The results indicate that administration of N-demethylated as well as hydroxylated metabolites may result in inhibition of the metabolism of their precursor. If hydroxylated metabolites are formed in situ they become more easily conjugated in comparison with administered hydroxylated metabolites and are therefore less effective as inhibitor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863150     DOI: 10.1007/BF03189692

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  32 in total

1.  A reliable, sensitive, and convenient radioactive assay for benzpyrene monooxygenase.

Authors:  J W DePierre; M S Moron; K A Johannesen; L Ernster
Journal:  Anal Biochem       Date:  1975-02       Impact factor: 3.365

2.  Spectral studies on the interaction of imipramine and some of its oxidized metabolites with rat liver microsomes.

Authors:  C von Bahr; S Orrenius
Journal:  Xenobiotica       Date:  1971-01       Impact factor: 1.908

3.  Effect of phenobarbital on the in vitro metabolism of diazepam in several animal species.

Authors:  F Marcucci; R Fanelli; E Mussini; S Garattini
Journal:  Biochem Pharmacol       Date:  1970-05       Impact factor: 5.858

4.  Interaction of uridine 5'-diphosphoglucuronic acid (UDPGA) with cytochrome P 450.

Authors:  E M Savenije-Chapel; A Bast; J Noordhoek
Journal:  J Pharm Pharmacol       Date:  1983-08       Impact factor: 3.765

5.  Biliary excretion of diazepam in the rat.

Authors:  T Inaba; E Tsutsumi; W A Mahon; W Kalow
Journal:  Drug Metab Dispos       Date:  1974 Sep-Oct       Impact factor: 3.922

6.  Product inhibition during the hepatic microsomal N-demethylation of aminopyrine in the rat.

Authors:  A Bast; J Noordhoek
Journal:  Biochem Pharmacol       Date:  1981-01-01       Impact factor: 5.858

7.  Rates of sulfation and glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.

Authors:  J G Conway; F C Kauffman; S Ji; R G Thurman
Journal:  Mol Pharmacol       Date:  1982-09       Impact factor: 4.436

Review 8.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

9.  Dose-dependent kinetics of aminopyrine metabolism in the rat caused by product inhibition and determined by capillary GLC.

Authors:  A Bast; L W Scheefhals; J Noordhoek
Journal:  Pharmacology       Date:  1982       Impact factor: 2.547

10.  Difference between single and multiple dose pharmacokinetics of orphenadrine hydrochloride in man.

Authors:  J J Labout; C t Thijssen; G G Keijser; W Hespe
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more
  1 in total

1.  Concentration-dependent metabolism of diazepam in mouse liver.

Authors:  M V St-Pierre; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1995-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.